Phase II study of Gleevec/imatinib mesylate (STI-571, NSC 716051) in neurofibromatosis (NF1) patients with plexiform neurofibromas
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Imatinib (Primary)
- Indications Plexiform neurofibroma
- Focus Therapeutic Use
- 23 Nov 2006 New trial record.